iNKT Cells Therapy(Gene Key Life)

N/A

Report date: 2024/12/20 15:22:34

Base Information

Drug NameiNKT Cells Therapy(Gene Key Life)
Drug Alias NameVα24+ T Cells(Gene Key Life)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > NKT cell therapy > Invariant natural killer T cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Gene Key Life Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Gene Key Life Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A